Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsAll products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Lysozymes, also known as muramidase or N-acetylmuramide glycanhydrolase, are glycoside hydrolases. These are enzymes (EC 3.2.1.17) that damage bacterial cell walls by catalyzing hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins. Lysozyme is abundant in a number of secretions, such as tears, saliva, human milk, and mucus. It is also present in cytoplasmic granules of the macrophages and the polymorphonuclear neutrophils (PMNs). Large amounts of lysozyme can be found in egg white. C-type lysozymes are closely related to alphalactalbumin in sequence and structure, making them part of the same family.
Loading...
| CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
| TCR-L049 | Pig anti-LYZ [46-61] T Cell Receptor, pLXSN | Chicken | Pig | LYZ[46-61] | retroviral vector | |||
| TCR-L048Z | Pig anti-LYZ (aa46-61) T cell receptor, pCDTCR1 | Chicken | Pig | LYZ[46-61] | Lentiviral | |||
| TCR-YC0637 | Mouse anti-LYZ T cell receptor (72.1), pCDTCR1 | Chicken | 72.1 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0638 | Mouse anti-LYZ T cell receptor (#1-1-14), pCDTCR1 | Chicken | #1-1-14 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0639 | Mouse anti-LYZ T cell receptor (#1-1-18), pCDTCR1 | Chicken | #1-1-18 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0640 | Mouse anti-LYZ T cell receptor (#1-1-50), pCDTCR1 | Chicken | #1-1-50 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0641 | Mouse anti-LYZ T cell receptor (#1-1-51), pCDTCR1 | Chicken | #1-1-51 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0642 | Mouse anti-LYZ T cell receptor (#1-1-62), pCDTCR1 | Chicken | #1-1-62 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0643 | Mouse anti-LYZ T cell receptor (#1-1-63), pCDTCR1 | Chicken | #1-1-63 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0644 | Mouse anti-LYZ T cell receptor (#1-1-74), pCDTCR1 | Chicken | #1-1-74 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0645 | Mouse anti-LYZ T cell receptor (#1-1-78), pCDTCR1 | Chicken | #1-1-78 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0646 | Mouse anti-LYZ T cell receptor (#1-2-10), pCDTCR1 | Chicken | #1-2-10 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0647 | Mouse anti-LYZ T cell receptor (#1-2-12), pCDTCR1 | Chicken | #1-2-12 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0648 | Mouse anti-LYZ T cell receptor (#1-2-14), pCDTCR1 | Chicken | #1-2-14 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0649 | Mouse anti-LYZ T cell receptor (#1-2-34), pCDTCR1 | Chicken | #1-2-34 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0650 | Mouse anti-LYZ T cell receptor (#1-2-38), pCDTCR1 | Chicken | #1-2-38 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0651 | Mouse anti-LYZ T cell receptor (#1-2-50), pCDTCR1 | Chicken | #1-2-50 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0652 | Mouse anti-LYZ T cell receptor (#1-2-54), pCDTCR1 | Chicken | #1-2-54 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-YC0653 | Mouse anti-LYZ T cell receptor (#1-2-89), pCDTCR1 | Chicken | #1-2-89 | Mouse | AMKRHGLDNYREYSLGN | H2-IAg7 | Lentiviral vector | |
| TCR-ZP136 | Mouse anti-LYZ T cell receptor (3A9), pCDTCR1 | Gallus gallus | 3A9 | Mouse | DGSTDYGILQINSRWW | HLA-DR | Lentiviral vector |
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
